13G Filing: Paulson & Co and Enzymotec Ltd (ENZY)

(a)	Amount beneficially owned: 2,102,990 Ordinary Shares (see Note 1)

(b)	Percent of Class: 9.17%

The aggregate percentage of Ordinary Shares reported herein is based upon 22,852,544 shares of Ordinary Shares outstanding as of December 31, 2016 which is the total number of shares of Ordinary Shares outstanding as reported in the Issuer’s Annual Report on Form 20-F filed with the Securities and Exchange Commission on March 16, 2017.

(c)	Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: 2,102,990 Ordinary Shares.

(iii)

Sole power to dispose or to direct the disposition of: 2,102,990 Ordinary Shares.

Note 1: Paulson & Co. Inc. (“Paulson”), an investment advisor that is registered under the Investment Advisors Act of 1940, and its affiliates furnish investment advice to and manage onshore and offshore investment funds and separate managed accounts (such investment funds and accounts, the “Funds”).  In its role as investment advisor, or manager, Paulson possesses voting and/or investment power over the securities of the Issuer described in this schedule that are owned by the Funds.  All securities reported in this schedule are owned by the Funds.  Paulson disclaims beneficial ownership of such securities.

Item 5.

Ownership of Five Percent or Less of a Class.

Not applicable.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

The private investment funds for which Paulson & Co. Inc. acts as investment adviser have the right to participate in the receipt of dividends from, and proceeds from the sale of, the Ordinary Shares held for the accounts of such funds.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

Not applicable.

Item 8.

Identification and Classification of Members of the Group.

Not applicable.

Item 9.

Notice of Dissolution of Group.

Not applicable.